HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,117,656 | +5.9% | 29,258 | -0.0% | 0.03% | +10.7% |
| Q2 2023 | $1,055,552 | -7.9% | 29,264 | -2.4% | 0.03% | -6.7% |
| Q1 2023 | $1,145,624 | +60.9% | 29,998 | +139.7% | 0.03% | +57.9% |
| Q4 2022 | $711,990 | -9.5% | 12,513 | -37.1% | 0.02% | -5.0% |
| Q3 2022 | $787,000 | -22.5% | 19,899 | -13.8% | 0.02% | -16.7% |
| Q2 2022 | $1,016,000 | +8.9% | 23,091 | -1.2% | 0.02% | +14.3% |
| Q1 2022 | $933,000 | -0.5% | 23,383 | +0.2% | 0.02% | +16.7% |
| Q4 2021 | $938,000 | -1.9% | 23,339 | -0.7% | 0.02% | -10.0% |
| Q3 2021 | $956,000 | -5.5% | 23,512 | +5.5% | 0.02% | +11.1% |
| Q2 2021 | $1,012,000 | +14.5% | 22,290 | +5.1% | 0.02% | +12.5% |
| Q1 2021 | $884,000 | -52.6% | 21,211 | -51.5% | 0.02% | -36.0% |
| Q4 2020 | $1,866,000 | – | 43,691 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |